Abstract

The interferon signalling system elicits a robust cytokine response against a wide range of environmental pathogenic and internal pathological signals, leading to induction of a subset of interferon-induced proteins. We applied DSS (disuccinimidyl suberate) mediated cross-linking mass spectrometry (CLMS) to capture novel protein–protein interactions within the realm of interferon induced proteins. In addition to the expected interferon-induced proteins, we identified novel inter- and intra-molecular cross-linked adducts for the canonical interferon induced proteins, such as MX1, USP18, OAS3, and STAT1. We focused on orthogonal validation of a cohort of novel interferon-induced protein networks formed by the HLA-A protein (H2BFS-HLA-A-HMGA1) using co-immunoprecipitation assay, and further investigated them by molecular dynamics simulation. Conformational dynamics of the simulated protein complexes revealed several interaction sites that mirrored the interactions identified in the CLMS findings. Together, we showcase a proof-of-principle CLMS study to identify novel interferon-induced signaling complexes and anticipate broader use of CLMS to identify novel protein interaction dynamics within the tumour microenvironment.

Details

Title
Identification of novel interferon responsive protein partners of human leukocyte antigen A (HLA-A) using cross-linking mass spectrometry (CLMS) approach
Author
Singh, Ashita 1 ; Padariya, Monikaben 2 ; Faktor, Jakub 2 ; Kote, Sachin 2 ; Mikac, Sara 2 ; Dziadosz, Alicja 2 ; Lam, Tak W. 3 ; Brydon, Jack 3 ; Wear, Martin A. 4 ; Ball, Kathryn L. 3 ; Hupp, Ted 5 ; Sznarkowska, Alicja 2 ; Vojtesek, Borek 6 ; Kalathiya, Umesh 2 

 University of Edinburgh, Institute of Genetics and Cancer, Edinburgh, Scotland, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); Masaryk University, Department of Experimental Biology, Faculty of Science, Brno, Czech Republic (GRID:grid.10267.32) (ISNI:0000 0001 2194 0956) 
 University of Gdansk, International Centre for Cancer Vaccine Science, Gdansk, Poland (GRID:grid.8585.0) (ISNI:0000 0001 2370 4076) 
 University of Edinburgh, Institute of Genetics and Cancer, Edinburgh, Scotland, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988) 
 University of Edinburgh, School of Biological Sciences, Institute of Structural and Molecular Biology, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988) 
 University of Edinburgh, Institute of Genetics and Cancer, Edinburgh, Scotland, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); University of Gdansk, International Centre for Cancer Vaccine Science, Gdansk, Poland (GRID:grid.8585.0) (ISNI:0000 0001 2370 4076) 
 Masaryk Memorial Cancer Institute, RECAMO, Brno, Czech Republic (GRID:grid.419466.8) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2735578701
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.